GLP-1 receptor agonists, including semaglutide, have also been associated with an increased risk of gallbladder disease, including cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation)
While these findings are encouraging, the studies highlighted show an association, not cause and effect, and thus more research is needed to confirm these findings in other populations
This aids in identifying patterns and adjusting if necessary
GLP-1 support is a holistic, science-based approach to amplifying the benefits of GLP-1 receptor agonists
The combined activation of GIPR and GLP-1R by tirzepatide not only improved both glucose-dependent insulin secretion and glucose tolerance in mice 15 , but also showed significantly better efficacy than semaglutide and dulaglutide with regard to glucose control and weight loss 16,17
Does the timing of the test affect the accuracy of a pregnancy test